期刊文献+

美金刚联合小牛血去蛋白提取物治疗老年性痴呆的临床观察 被引量:1

Clinical Observation on the Effect of Memantine Combined with Deproteinized Hemoderivative of Calf Blood on Alzheimer's Disease
下载PDF
导出
摘要 目的探讨联合应用美金刚(易倍申)和小牛血去蛋白提取物(鸿源)对老年性痴呆患者认知功能和行为能力的改善作用。方法 92例老年性痴呆患者随机分为两组,治疗组46例采用美金刚与小牛血去蛋白提取物治疗,对照组46例仅采用美金刚治疗。治疗前与治疗12周后评价简易智能精神状态评估量表(MMSE)、日常生活功能量表(ADL)、长谷川痴呆量表(HDS)、韦氏记忆量表(WMS)。结果治疗组治疗后MMSE、ADL、HDS、WMS评分较对照组均有明显改善,差异有统计学意义(P<0.05)。治疗组治疗前后评分亦有显著改善,差异有统计学意义(P<0.05)。结论美金刚和小牛血去蛋白提取物联合治疗对老年性痴呆患者认知、行为能力等均有显著改善作用。 Objective To investigate the effect of combination therpy of memantine and calf blood deproteinized extracts on the cognitive function and behavior capacity of patients with senile dementia. Methods Ninety-two cases of senile dementia patients were randomly divided into two groups. Treatment group: 46 cases, 12 weeks of treatment total, memantine 20 mg oral each day, and received the calf blood deproteinized extract 800 mg with normal saline intravenous infusion of 250 mL per day for two weeks. Control group of 46 patients with memantine 20 mg orally, 12 weeks of treatment as well. Before and after 12 weeks of treatment, the mini mental status assessment scale (MMSE), activities of daily living scale (ADL), Hascgawa's dementia scale (HDS), Wechsler's Memory Scale(WMS) were evaluated. Results After treatment, the MMSE, ADL, HDS, and WMS scores of the treatment group showed significant improvement compared with the control group, with statistically significant difference (P 〈0.05). The scores after treatment in the treatment group also significantly improved than those before treatment, with statistically significant difference (P 〈0.05). Conclusions Combined treatment of memantine and calf blood deproteinized extracts can significantly improve cognition and behavior ability in the senile dementia patients.
作者 黄健
出处 《临床医学工程》 2013年第1期41-42,共2页 Clinical Medicine & Engineering
关键词 美金刚 老年性痴呆 认知功能 Memantine Alzheimer's disease Cognitive function
  • 相关文献

参考文献12

  • 1赵莘瑜,许予明,常程.美金刚治疗轻中度阿尔茨海默病32例临床观察[J].山东医药,2009,49(43):90-91. 被引量:4
  • 2Gamaldo A, Moghekar A, Kilada S, et ol. Effect of a clinical stroke on the risk of dementia in a prospective cohort [J] . Neurology, 2006, 67 (8) : 1363-1369.
  • 3Regan C, Katona C, Walker Z, et aL Relationship of vascular risk to the progression of Alzheimer disease [J] . Neurology, 2006, 67(8) : 1357-1362.
  • 4于洪儒,肖建英,刘用璋,张敬国,李红.促细胞代谢素注射液生物活性的实验研究[J].中国新药杂志,2000,9(2):96-98. 被引量:24
  • 5American Psychiatry Association. Diagnostic and statistical manual of mental disorders-DSM-IV [M] . 4^th ed. Washington American Psychi- atric Press, 1994: 147-154.
  • 6Johnson JW, Kotermanski SE. Mechanism of action of memantine [J] . Curr Opin Pharmacol, 2006, 6 (1) : 61-67.
  • 7Wenk GL. Neuropathologic changes in Alzheimer's disease: potential targets for treatment [J] . J Clin Psychiatry, 2006, 67 Suppl 3: 3-7.
  • 8Schmitt HP. On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease [J] .Med Hypotheses, 2005, 65 (2) : 259-265.
  • 9Schmitt F, Ryan M, Cooper G. A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease [J] . Expert Opin DrugMetab Toxicol, 2007, 3 (1) : 135-141.
  • 10Beach TG, Wilson JR, Sue LI, et al. Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibril- lary tangles [J] .ActaNeuropathol, 2007, 113 (1):13-21.

二级参考文献20

  • 1张效溥,田杰,孙宗翰,欧阳华.基于任意传感器排布的叶尖定时信号压缩感知辨识方法[J].航空动力学报,2020,35(1):41-51. 被引量:9
  • 2Cummings JL, Cole G . Alzheimer disease[J] JAMA,2002,287 ( 17 ) :2335-2338.
  • 3Samanta MK, Wilson B, Santhi K, et al. Alzheimer disease and it, s management :a review[J ] . Am J Ther, 2006,13 (6) :516- 520.
  • 4Wenk GL. Neuropathologie changes in Alzheimer's disease : potential targets for treatment [ J ] . J Clin Psychiatry, 2006,67 (Suppl 3) :3-6.
  • 5Parsons CG, DanyszW, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate ( NMDA ) receptor antagonist-areview ofp reclinical data[ J ]. Ncuropharmacology, 1999, 38(6) : 735 -767.
  • 6Sehmitt F, Ryan M, Cooper G. A brief review of the pharmacologic and therapeutic aspect s of memantine in Alzheimer's disease [ J ] . Expert Opin Drug Metab ToxiCol, 2007,3 (1) :135-140.
  • 7Bakchinea S, Loft H. Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double- Blind, Placebo-Controlled 6-Month Study [ J ]. Journal of Alzheimer's Disease, 2007,11 (8) : 471-479.
  • 8Reisberg B, DoodyR, StofllerA, et al. Memantine in moderate-tosevere Alzheimer s disease [ J]. N Engl J Med, 2003, 348(14) : 1333-1341.
  • 9Reisberg B, DoodyR, StofflerA, et al. A 24-week open-label extension study of memantine inmoderate to severe Alzheimer disease [J]. ArchNeurol, 2006, 63(1 ): 49-54.
  • 10李孟麟,段发阶,欧阳涛,孔祥洪,季茂林.基于叶尖定时的旋转机械叶片振动频率辨识ESPRIT方法[J].振动与冲击,2010,29(12):18-21. 被引量:9

共引文献26

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部